Company intelligence / Profile preview

AMAG Pharmaceuticals, Inc.

Waltham, Massachusetts, United States of Americaamagpharmadev.wpengine.com ↗

Ownership: Private
Employees: ~440
Development stage: Commercial

Overview

AMAG Pharmaceuticals developed and commercialized specialty pharmaceutical products focused on maternal health, anemia management, and women's health. The company was acquired by Covis Pharma in November 2020.

Therapeutic areas: Women's HealthHematologyImmunologyInfectious Diseases
Modalities: Small molecule drugs
Industry: Biotech

Drug pipeline

2 assets

ferumoxytol

Commercial

Indications: Iron deficiency anemia, Chronic kidney disease

1 more asset in the full pipeline.

Request access →

Partnerships

Norgine B.V.Endoceutics, Inc.Palatin Technologies, Inc.Velo Bio, LLCPrasco, LLCPerosphere Pharmaceuticals Inc.Antares Pharma, Inc.

Beyond the preview

Go deeper on AMAG Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMAG Pharmaceuticals, Inc..

Explore the full profile